Pharmacology Seminar Series
| Date | Time | Speaker | Title | Location |
|---|---|---|---|---|
| August 28, 2024 | 12 pm | TBD | TBD | MED 209L |
| September 4, 2024 | 12 pm | Co-Hosted by the Pain/Immunology Cluster of School of Dentistry Kathleen A. Sluka, PT, PhD, FAPTA Department of Physical Therapy and Rehabilitation Science Carver College of Medicine University of Iowa Iowa City, Iowa | TBD | MED 209L |
| September 11, 2024 | 12pm | TBD | TBD | MED 209L |
| September 18, 2024 | 12pm | Martin C. Michel, PhD Department of Pharmacology University Medical Center of the Johannes Gutenberg University Mainz Germany | TBD | MED 209L |
| September 25, 2024 | 12pm | TBD | TBD | MED 209L |
| October 2, 2024 | 12pm | Jennifer Rauch, PhD Department of Biochemistry and Molecular Biology University of Massachusetts Amherst Life Science Laboratories Amherst, MA | TBD | MED 209L |
| October 16, 2024 | 12pm | Xinli Liu, PhD Department of Pharmacological and Pharmaceutical Sciences UH Drug Discovery Institute University of Houston Houston Texas | TBD | MED 209L |
| October 24, 2024 | 4pm | 4th Annual Alan Frazer Lectureship Barbara S. Slusher, PhD, MAS Neurology, Psychiatry, Pharmacology, Neuroscience, Medicine, Oncology Pederson Brain Science Institute Johns Hopkins School of Medicine Baltimore, Maryland | TBD | MED 209L |
| October 30, 2024 | 12pm | Stefanie Robel, PhD Department of Cell, Developmental and Integrative Biology The University of Alabama at Birmingham Birmingham, Alabama | Mechanisms mediating an atypical astrocyte response and prolonged blood-brain barrier disruption after mild traumatic brain injury/concussion | MED 209L |
| November 6, 2024 | 12pm | Mark J. Ferris, PhD Department of Translational Neuroscience Center for Research on Substance Use and Addiction Wake Forest Tobacco Control Center of Excellence Wake Forest University Winston-Salem, North Carolina | TBD | MED 209L |
| November 13, 2024 | 12pm | Shaun K. Olsen, PhD Department of Biochemistry & Structural Biology UT Health San Antonio San Antonio, Texas | TBD | MED 209L |
| November 20, 2024 | 12pm | Gabriel A. de Erausquin, MD, PhD, MSc Biggs Research Institute UT Health San Antonio San Antonio, Texas | Mechanism of susceptibility of dopaminergic neurons to AMPA-mediated excitotoxicity | MED 209L |
| December 4, 2024 | 12pm | Benita Sjogren, PhD Department of Pharmaceutical Sciences School of Pharmacy & Pharmaceutical Sciences University of California, Irvine Irvine, California | TBD | MED 209L |
| December 18, 2024 | 12pm | Margaret E. Flanagan, MD Department of Pathology and Laboratory Medicine UT Health San Antonio San Antonio, Texas | TBD | MED 209L |